Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study

An emerging issue in neuroimaging is to assess the diagnostic reliability of PET and its application in clinical practice. We aimed at assessing the accuracy of brain FDG-PET in discriminating patients with MCI due to Alzheimer's disease and healthy controls. Sixty-two patients with amnestic MC...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagani, M., De Carli, F., Morbelli, S., Öberg, J., Chincarini, A., Frisoni, G.B., Galluzzi, S., Perneczky, R., Drzezga, A., van Berckel, B.N.M., Ossenkoppele, R., Didic, M., Guedj, E., Brugnolo, A., Picco, A., Arnaldi, D., Ferrara, M., Buschiazzo, A., Sambuceti, G., Nobili, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299956/
https://www.ncbi.nlm.nih.gov/pubmed/25610765
http://dx.doi.org/10.1016/j.nicl.2014.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299956/
https://www.ncbi.nlm.nih.gov/pubmed/25610765
http://dx.doi.org/10.1016/j.nicl.2014.11.007

Ejemplares similares